MERRF Syndrome < MPTP Poisoning < Macaca

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 37.
[20-40] [0 - 20][0 - 37]

Ident.	Authors (with country if any)	Title
001059 (2003)	Erwan Bézard [France] ; Sandrine Ferry ; Ulrich Mach ; Holger Stark ; Ludovic Leriche ; Thomas Boraud ; Christian Gross ; Pierre Sokoloff	Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.
001067 (2003)	Olga Corti [France] ; Alexis Brice	[Parkinson's disease: what have we learned from the genes responsible for familial forms?].
001256 (2000)	C. François [France] ; C. Savy ; C. Jan ; D. Tande ; E C Hirsch ; J. Yelnik	Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients.
001265 (2000)	E. Bezard [France] ; M. Jaber ; F. Gonon ; A. Boireau ; B. Bloch ; C E Gross	Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.
001330 (1999)	C. Fillebeen [France] ; V. Mitchell ; D. Dexter ; M. Benaissa ; J. Beauvillain ; G. Spik ; A. Pierce	Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.
001436 (1998)	T. Boraud [France] ; E. Bezard ; D. Guehl ; B. Bioulac ; C. Gross	Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey.
001462 (1997)	E. Bezard [France] ; S. Dovero ; B. Bioulac ; C. Gross	Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice.
001502 (1997)	M. Vila [France] ; R. Levy ; M T Herrero ; M. Ruberg ; B. Faucheux ; J A Obeso ; Y. Agid ; E C Hirsch	Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
001545 (1996)	M. Vila [France] ; R. Levy ; M T Herrero ; B. Faucheux ; J A Obeso ; Y. Agid ; E C Hirsch	Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.
001550 (1996)	M. Vila [France] ; M T Herrero ; R. Levy ; B. Faucheux ; M. Ruberg ; J. Guillen ; M R Luquin ; J. Guridi ; F. Javoy-Agid ; Y. Agid ; J A Obeso ; E C Hirsch	Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.
001577 (1995)	A. Benazzouz [France] ; T. Boraud ; P. Dubédat ; A. Boireau ; J M Stutzmann ; C. Gross	Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study.
001587 (1995)	R. Levy [France] ; M T Herrero ; M. Ruberg ; J. Villares ; B. Faucheux ; J. Guridi ; J. Guillen ; M R Luquin ; F. Javoy-Agid ; J A Obeso	Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA.
001616 (1994)	M. Varastet [France] ; D. Riche ; M. Maziere ; P. Hantraye	Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease.
001663 (1993)	M T Herrero [France] ; A. Kastner ; I. Perez-Ota O ; E C Hirsch ; M R Luquin ; F. Javoy-Agid ; J. Del Río ; J A Obeso ; Y. Agid	Gangliosides and parkinsonism.
001667 (1993)	M T Herrero [France] ; E C Hirsch ; A. Kastner ; M. Ruberg ; M R Luquin ; J. Laguna ; F. Javoy-Agid ; J A Obeso ; Y. Agid	Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
001683 (1993)	P. Hantraye [France] ; M. Varastet ; M. Peschanski ; D. Riche ; P. Cesaro ; J C Willer ; M. Maziere	Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.
001813 (1989)	M. Zreika [France] ; J R Fozard ; M W Dudley ; P. Bey ; I A Mcdonald ; M G Palfreyman	MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "MPTP Poisoning" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "MPTP Poisoning" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    MPTP Poisoning
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024